SC1-BHC-07-2019
SC1-BHC-07-2019
14 projects · €105,138,455 total EU contribution (project-level) · 127 participating organizations · 18 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€105,138,455
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (18)
- Spain (18)
- France (14)
- Netherlands (14)
- UK (11)
- CH (10)
- Italy (10)
- BE (5)
- AT (4)
- DK (4)
- IE (4)
- SE (4)
- PT (3)
- AU (2)
- CZ (2)
- EL (2)
- FI (1)
- IL (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- INSERM4 projects · FR
- Fraunhofer3 projects · DE
- UNIVERSITEIT MAASTRICHT3 projects · NL
- Leiden University Medical Center2 projects · NL
- AO-FORSCHUNGSINSTITUT DAVOS2 projects · CH
- CNIC2 projects · ES
- CSEM2 projects · CH
- ETHRIS2 projects · DE
- EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH2 projects · DE
- UGOT - GOETEBORGS UNIVERSITET/UNIVERSITY OF GOTHENBURG2 projects · SE
- HMGU2 projects · DE
- INSERM TRANSFERT SA2 projects · FR
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Novel Strategies for Cell-based Neural Reconstruction NSC-Reconstruct · 874758 | H2020 | €8,168,495 | €500,000 | Details |
Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis AutoCRAT · 874671 | H2020 | €7,452,770 | €783,101 | Details |
3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients cmRNAbone · 874790 | H2020 | €6,256,759 | €0 | Details |
Controlled Organoids transplantation as enabler for regenerative medicine translation ORGANTRANS · 874586 | H2020 | €6,301,156 | €257,500 | Details |
Anchored Muscle cELls for IncontinencE AMELIE · 874807 | H2020 | €9,526,097 | €459,913 | Details |
New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes VANGUARD · 874700 | H2020 | €6,844,625 | €701,250 | Details |
Brain injury in the premature born infant: stem cell regeneration research network PREMSTEM · 874721 | H2020 | €8,999,620 | €59,418 | Details |
Gene Therapy to restore lymphatic flow lymphedema TheraLymph · 874708 | H2020 | €8,064,946 | €317,288 | Details |
Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe ISLET · 874839 | H2020 | €7,999,999 | €801,056 | Details |
PRECISION MANUFACTURING OF MICROENGINEERED COMPLEX JOINT IMPLANTS JOINTPROMISE · 874837 | H2020 | €7,901,115 | €2,043,693 | Details |